Eps Corp operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eps Corp with three other
miscellaneous service companies in Asia:
Takara Bio Inc
sales of 29.73 billion Japanese Yen [US$257.45 million]
of which 92%
was Bio support),
Syngene International Ltd
(11.07 billion Indian Rupees [US$162.06 million]
Shin Nippon Biomedical Laboratories Ltd
(14.75 billion Japanese Yen [US$127.74 million]
of which 80%
was Pre-Clinical Business).
Eps Corp reported sales of ¥52.70 billion (US$456.41 million)
September of 2016.
increase of 16.6%
versus 2015, when the company's sales were ¥45.20 billion.
Sales at Eps Corp have increased during each of the previous five years
(and since 2011, sales have increased a total of 64%).
Sales of Smo Business saw an increase
that was more than double the company's growth rate: sales were up
68.6% in 2016, from
¥6.45 billion to ¥10.87 billion.
Eps Corp also saw significant increases in sales in
Global Research Business (up 47.1% to ¥4.01 billion)
Others (up 58.8% to ¥1.49 billion)
Not all segments of Eps Corp experienced an increase in sales in 2016:
sales of Eps Business fell 7.4% to ¥3.94 billion.